Market failures and opportunities for increasing access to diagnostics in low- and middle-income countries
Diagnostics are fundamental to accurate detection of disease and critical to informing effective clinical care and selection of treatment. Yet access to diagnostic testing has remained poor and inequitable in many parts of the world. Approximately 47 percent of the global population has little to no access to diagnostics. This challenge is particularly evident in low- and middle-income countries, where only 19 percent of patients have access to appropriate diagnostics at the primary health care level.
To develop this report, PATH collaborated with Accenture to investigate access challenges within the diagnostics ecosystems in Latin America, Africa, and Southeast Asia to identify market failures and market-shaping interventions needed for LMICs and close the existing diagnostics gap. The report highlights existing market failures across the diagnostics value chain and provides recommendations for expanded access to quality diagnostics in low- and middle-income countries.
Click here to view an interactive dashboard of diagnostic companies with a manufacturing presence based in Africa, Latin America, and Southeast Asia.
Publication date: September 2022